SecBot SecBot
8-K ·Filed May 7, 2026

MCK

MCKESSON CORP
BULLISH
Impact 8/10
Horizondays Processed6mo ago SEC0000927653-26-000066
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

Watch for continued execution on the Medical-Surgical spin-off and synergy from the Apollo partnership. The raised guidance signals confidence in sustained 12-14% EPS growth, which could drive further multiple expansion. Monitor the Q1 FY2027 call for progress on segment separation.

DirectionBullish
Confidencehigh
Horizondays

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$732.70
T+0 close · May 7, 2026 · via day close
Latest settled
+12.89%
T+60 · $827.14
Vs SPY
+10.17%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 8 $732.70entry
  2. T+1 · 6mo ago −1.10%α −1.33% · $724.62
  3. T+5 · 6mo ago +1.98%α +0.52% · $747.23
  4. T+20 · 5mo ago +5.86%α +5.84% · $775.66
  5. T+60 · 3mo ago +12.89%α +10.17% · $827.14

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

McKesson reported a strong Q4 FY2026 with GAAP EPS of $13.71 (+37% YoY) and Adjusted EPS of $11.69 (+16% YoY) on revenue of $96.3B (+6% YoY). Full year Adjusted EPS grew 18% to $39.11, above long-term targets. The company raised FY2027 Adjusted EPS guidance to $43.80-$44.60 (12-14% growth), announced a $5B share repurchase increase, and signed a deal for Apollo Global to acquire a 13% minority stake in its Medical-Surgical segment.

Key Financial Metrics

Free Cash Flow
$3.2B

Key Facts

  • Q4 FY2026 GAAP EPS $13.71 (up 37% YoY), Adjusted EPS $11.69 (up 16% YoY)
  • Q4 revenue $96.3B (up 6% YoY), full year revenue $403.4B (up 12% YoY)
  • FY2027 Adjusted EPS guidance $43.80-$44.60 (12-14% growth)
  • $5.0B increase to share repurchase authorization, total $7.7B; $2.25B ASR completed in Q4
  • Apollo Global to acquire ~13% minority stake in Medical-Surgical segment
  • Cash flow from operations $3.4B and Free Cash Flow $3.2B in Q4

Financial Impact

Strong earnings beat with 16% adjusted EPS growth, raised guidance, and significant capital return

revenueepsguidancecash flow

Risk Factors

  • Opioid litigation remains a long-term overhang with $5.1B in long-term litigation liabilities
  • Execution risk on Medical-Surgical separation and minority stake closing
  • Potential headwinds from branded pharmaceutical pricing pressure

Market Snapshot

Exchange
NYSE
Sector
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Analyst Consensus
87% bullish (23 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000927653-26-000066
Document: mck-20260507.htm0000927653-26-000066
Document: 0000927653-26-000066-index-headers.html0000927653-26-000066
Document: 0000927653-26-000066-index.html0000927653-26-000066
Document: 0000927653-26-000066.txt0000927653-26-000066
8-K Data (Synthetic)0000927653-26-000066

Track record

26 reports on MCK

Performance horizon

4 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +22.92% at T+60 after the Apr 1, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 5, 202612d ago 144 Neutral 2/10 Entry $1,072.00 to $1,077.05 Now $1,091.52 +1.82% ▲ +0.47% −2.82% vs SPY
  2. Nov 4, 202612d ago 144 Neutral 2/10 Entry $1,072.00 to $1,077.05 Now $1,091.52 +1.82% ▲ +0.47% −2.82% vs SPY
  3. Nov 4, 202613d ago 8-K Bullish 6/10 Entry $1,072.00 to $1,077.05 Now $1,091.52 +1.82% ▲ +0.47% −2.82% vs SPY
  4. Oct 30, 202618d ago 25-NSE Neutral 1/10 Entry $994.58 to $1,060.84 Now $1,091.52 +9.75% ▲ +6.66% +9.37% vs SPY
  5. Oct 28, 202620d ago Institutional Cluster Neutral 3/10 Entry $960.56 to $1,069.44 Now $1,091.52 +13.63% ▲ +11.34% +12.05% vs SPY
  6. Oct 27, 202621d ago GOVT-CONTRACT Neutral 3/10 Entry $960.56 to $1,069.44 Now $1,091.52 +13.63% ▲ +11.34% +12.05% vs SPY
  7. Oct 12, 20265w ago Institutional Cluster Mixed 4/10 Entry $955.76 to $1,010.43 Now $1,091.52 +14.20% ▲ +5.72% +7.21% vs SPY
  8. Oct 6, 20266w ago 8-K Bullish 6/10 Entry $921.67 to $961.88 Now $1,091.52 +18.43% ▲ +4.36% +4.50% vs SPY
  9. Sep 1, 202611w ago GOVT-CONTRACT Neutral 3/10 Entry $924.78 to $880.86 Now $1,091.52 +18.03% ▼ −4.75% −3.79% vs SPY
  10. Aug 28, 202611w ago 8-K Neutral 4/10 Entry $885.32 to $896.29 Now $1,091.52 +23.29% ▲ +1.24% +1.38% vs SPY
Showing 10 of 26

US Market Status

Market Closed · Opens Wed (17h 22m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 7, 2026